Aptus Capital Advisors, LLC Merck & Co., Inc. Call Options Transaction History

Aptus Capital Advisors, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $100 Million - $109 Million	1,000,000 New	1,000,000 $109 Million
Q3 2021 Oct 27, 2021	BUY	$71.68 - $78.83 $100 Million - $110 Million	1,400,000 Added 700.0%	1,600,000 $120 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $15.2 Million - $16.6 Million	200,000 New	200,000 $16.8 Million

3,826

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $278B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Aptus Capital Advisors, LLC with notifications on news.